Charmaine Roson - Philippines

“Even with the Philippines FDA extending the grace period, it’s still recommended that manufacturers seek registration at their earliest convenience.”

Charmaine Roson
Principal Consultant
Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sign Up For Our Newsletter to Stay Informed

Sign Up

Philippines Extends Grace Period for Registration of Certain Medical Devices

Published on: March 28th, 2022

Updated April 27th, 2022

On April 21, the Philippines FDA published the official Circular announcing an extension of the grace period for the mandatory registration of non-Notified class B, C, and D medical devices by 12 months.

With the release of the Circular, class B, C, and D medical devices that are not included in the specified list in Circular No. 2021-001-A may continue to be manufactured, imported/exported, distributed, and/or sold without an initial Certificate of Medical Device Notification (CMDN) until March 31, 2023. The importers of these devices are simply required to have a valid License To Operate (LTO) for Customs clearance and public tender qualification.

It should be noted that the Philippines FDA currently accepts and processes applications; and will issue Certificates of Medical Device Notification for these devices during the grace period.  Further, the stated purpose of the extension is to ensure continued availability of devices already on the market; and so new non-Notified devices not yet on the market in the Philippines are technically still subject to pre-market approval.

Grace Period Deadline

After the new grace periods ends, an initial CMDN or a pending application will be required for manufacturing, importing, distributing, and/or selling no-Notified Class B, C, and D devices. Three (3) months prior to the expiration of the CMDN, the local agent will need to apply for a CMDR and the issued CMDN and proof application for CMDR shall be provided at the point of entry and/or part of bidding requirements until the CMDR is approved.

For the latest information regarding the medical device registration process in the Philippines, click here.

Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today to see how new regulatory developments may affect your business in the Philippines.

Blog Posts

Japan's Innovative Medical Device Regulatory Pathway is called Sakigake

Innovative Medical Device Registration in Japan

In 2019, Japan's Ministry of Health, Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) introduced a innovative device registration designation system, called Sakigake, which is meant to streamline the regulatory pathway for qualifying medical products.
Read more
PMDA Representative consulting with medical device manufacturers in Japan

Medical Device Consultation in Japan

Medical device consultation in Japan is a very involved but essential process in registering a medical device. A significant part of the regulatory process in Japan is consultation meetings with the Pharmaceuticals and Medical Devices Agency (PMDA).
Read more
Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more